Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma (Q40010307)
Jump to navigation
Jump to search
scientific article published on 21 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma |
scientific article published on 21 February 2008 |
Statements
1 reference
Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma (English)
1 reference
Guido Marcucci
1 reference
Owen A O'Connor
1 reference
Mithat Gonen
1 reference
Jeffrey R Gardner
1 reference
Jill Mastrella
1 reference
Dajun Yang
1 reference
Jon Holmlund
1 reference
Mel Sorensen
1 reference
Lance Leopold
1 reference
Katia Manova
1 reference
Mark L Heaney
1 reference
21 February 2008
1 reference
5350-5358
1 reference
Identifiers
1 reference